Latham & Watkins partners Michele Johnson in Orange County and Colleen Smith in San Diego represented biopharmaceutical company Puma Biotechnology and its CEO in the first federal securities class action to reach a verdict in nearly 10 years alongside partner Andrew Clubok, based in Washington, D.C., and New York. Partner Elizabeth Deeley teamed with Clubok to win approval of a $35 million deal to resolve long-running securities class actions regarding Facebook’s IPO, setting important Second Circuit precedent on the way. Silicon Valley patent litigator Douglas Lumish teamed with partner Bert Reiser in D.C. to represent cloud networking company Arista Networks in its International Trade Commission showdown with larger rival Cisco. Lumish and Silicon Valley partner Rick Frenkel also teamed with D.C. partner Gabe Bell to secure Federal Circuit affirmance of a patent win for Facebook subsidiary WhatsApp.
That lineup of casework landed Latham as one of six finalists for the Tech Litigation Department of the Year as part of The Recorder’s California Leaders in Tech Law and Innovation Awards. The winner of the award will be announced at a ceremony celebrating all winners and finalists Nov. 6. In the run-up to next month’s announcement, The Recorder recently asked Johnson, the global chair of Latham’s litigation and trial department, about the firm’s approach to litigation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]